Medical Disposables & Supplies Past Earnings Performance

Past criteria checks 0/6

Medical Disposables & Supplies's earnings have been declining at an average annual rate of -15.5%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 13.3% per year.

Key information

-15.5%

Earnings growth rate

-15.7%

EPS growth rate

Healthcare Industry Growth	-2.9%
Revenue growth rate	13.3%
Return on equity	-6.9%
Net Margin	-1.9%
Last Earnings Update	31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medical Disposables & Supplies makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

JMSE:MDS Revenue, expenses and earnings (JMD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	3,699	-72	827
30 Sep 23	3,739	5	814
30 Jun 23	3,803	54	807
31 Mar 23	3,770	72	787
31 Dec 22	3,686	90	790
30 Sep 22	3,620	82	766
30 Jun 22	3,626	88	745
31 Mar 22	3,416	97	685
31 Dec 21	3,150	122	608
30 Sep 21	2,902	128	558
30 Jun 21	2,595	102	496
31 Mar 21	2,423	70	481
31 Dec 20	2,522	18	473
30 Sep 20	2,499	-1	448
30 Jun 20	2,434	12	438
31 Mar 20	2,481	35	429
31 Dec 19	2,367	87	380
30 Sep 19	2,302	101	375
30 Jun 19	2,238	110	356
31 Mar 19	2,222	113	340
31 Dec 18	2,140	101	320
30 Sep 18	2,123	113	307
30 Jun 18	2,106	113	306
31 Mar 18	2,045	110	299
31 Dec 17	1,942	97	292
30 Sep 17	1,852	95	281
30 Jun 17	1,769	98	266
31 Mar 17	1,714	101	255
31 Dec 16	1,667	96	247
30 Sep 16	1,555	91	233
30 Jun 16	1,462	95	219
31 Mar 16	1,327	96	210
31 Dec 15	1,229	95	205
30 Sep 15	1,218	89	203
30 Jun 15	1,193	87	199
31 Mar 15	1,159	85	188
31 Dec 14	1,096	77	176
30 Sep 14	1,024	71	164
30 Jun 14	966	62	149
31 Mar 14	913	57	135
31 Dec 13	975	69	136

Quality Earnings: MDS is currently unprofitable.

Growing Profit Margin: MDS is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MDS is unprofitable, and losses have increased over the past 5 years at a rate of 15.5% per year.

Accelerating Growth: Unable to compare MDS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (29.3%).

Return on Equity

High ROE: MDS has a negative Return on Equity (-6.85%), as it is currently unprofitable.

Medical Disposables & Supplies Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Recent updates

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

Revenue & Expenses Breakdown

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies